Marinus Pharmaceuticals (MRNS) Earnings Date, Estimates & Call Transcripts → Digitizing the $11T commodities sector with one tiny stock (From Resource Stock Digest) (Ad) Free MRNS Stock Alerts $1.50 +0.12 (+8.70%) (As of 02:33 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (May. 8) -$0.68 Consensus EPS (May. 8) -$0.68 Get Marinus Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for MRNS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMRNS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MRNS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade Marinus Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.76)($0.61)($0.69)Q2 20243($0.73)($0.52)($0.61)Q3 20243($0.67)($0.37)($0.53)Q4 20243($0.63)($0.11)($0.38)FY 202412($2.79)($1.61)($2.21)Q1 20251($0.47)($0.47)($0.47)Q2 20251($0.38)($0.38)($0.38)Q3 20251($0.31)($0.31)($0.31)Q4 20251($0.02)($0.02)($0.02)FY 20254($1.18)($1.18)($1.18)MRNS Earnings Date and InformationMarinus Pharmaceuticals last released its quarterly earnings results on May 8th, 2024. The biopharmaceutical company reported ($0.68) EPS for the quarter, meeting analysts' consensus estimates of ($0.68). The company earned $7.68 million during the quarter, compared to the consensus estimate of $8.61 million. Marinus Pharmaceuticals has generated ($2.64) earnings per share over the last year (($2.64) diluted earnings per share). Earnings for Marinus Pharmaceuticals are expected to grow in the coming year, from ($1.87) to ($0.90) per share. Marinus Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Marinus Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024(Estimated)------- 5/8/2024Q1 2024($0.68)($0.68)-($0.68)$8.61 million$7.68 million3/5/2024Q4 2023($0.64)($0.74)($0.10)($0.74)$7.78 million$7.19 million 11/7/2023Q3 2023($0.67)($0.61)+$0.06($0.61)$6.54 million$7.34 million8/10/2023Q2 2023($0.76)($0.61)+$0.15($0.61)$5.14 million$6.08 million 5/11/2023Q1 2023($0.77)($0.67)+$0.10($0.67)$5.33 million$10.38 million3/7/2023Q4 2022($0.91)($0.76)+$0.15($0.76)$13.32 million$7.16 million Get the Latest News and Ratings for MRNS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Marinus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/7/2022Q3 2022$0.25($0.35)($0.60)($2.59)$28.56 million$2.34 million8/11/2022Q2 2022($0.93)($1.06)($0.13)($1.06)$2.25 million$1.79 million5/12/2022Q1 2022($0.87)($0.52)+$0.35($0.52)$2.19 million$14.19 million3/21/2022Q4 2021($0.81)($0.77)+$0.04($0.77)$2.64 million$1.52 million 11/9/2021Q3 2021($0.76)($0.53)+$0.23($0.53)$2.32 million$10.11 million 8/10/2021Q2 2021($0.68)($0.65)+$0.03($0.65)$2.57 million$1.91 million 5/17/2021Q1 2021($0.46)($0.74)($0.28)($0.74)$2.61 million$1.81 million 3/8/2021Q4 2020($0.52)($0.55)($0.03)($0.55)$1.77 million$1.55 million 11/9/2020Q3 2020($0.60)($0.51)+$0.09($0.51)-- 8/6/2020Q2 2020($0.76)($0.64)+$0.12($0.16)--5/4/2020Q1 2020($0.64)($1.28)($0.64)($0.32)-- 3/16/2020Q4 2019($0.84)($1.00)($0.16)($0.26)--11/6/2019Q3($0.9480)($1.04)($0.0920)($0.26)--8/8/2019Q2 2019($0.9360)($0.96)($0.0240)($0.24)-- Marinus Pharmaceuticals Earnings - Frequently Asked Questions When is Marinus Pharmaceuticals's earnings date? Marinus Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on MRNS's earnings history. Did Marinus Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Marinus Pharmaceuticals (NASDAQ:MRNS) reported ($0.68) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.68). Learn more on analysts' earnings estimate vs. MRNS's actual earnings. How much revenue does Marinus Pharmaceuticals generate each year? Marinus Pharmaceuticals (NASDAQ:MRNS) has a recorded annual revenue of $28.29 million. How much profit does Marinus Pharmaceuticals generate each year? Marinus Pharmaceuticals (NASDAQ:MRNS) has a recorded net income of -$141.40 million. MRNS has generated -$2.64 earnings per share over the last four quarters. What is Marinus Pharmaceuticals's EPS forecast for next year? Marinus Pharmaceuticals's earnings are expected to grow from ($1.87) per share to ($0.90) per share in the next year. More Earnings Resources from MarketBeat Related Companies: RAPT Earnings Date NLTX Earnings Date NKTR Earnings Date MRSN Earnings Date XOMA Earnings Date NATR Earnings Date XERS Earnings Date MGNX Earnings Date EPIX Earnings Date RVNC Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: TD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's Earnings This page (NASDAQ:MRNS) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesThe only AI company to buyPorter & CompanyThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDigitizing the $11T commodities sector with one tiny stockResource Stock DigestBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsIs Artificial Intelligence the Biggest Bubble in History?InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marinus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
